# New Research Challenges Blood Pressure Targets for Stroke and Diabetes Patients Recent clinical trials reveal complex outcomes for aggressive blood pressure management in high-risk patients. - **Source:** [STAT](https://www.statnews.com) - **Published:** 2026-11-07 - **Topic:** [health](https://brifing.si/c/health) - **Original article:** - **On Brifing:** https://brifing.si/s/e5b30729-e3c6-4e9e-af03-6d42c1b15796 ## Hypertension as Silent Killer High blood pressure remains the leading modifiable risk factor for recurrent strokes and cardiovascular events. Patients with diabetes or previous strokes face significantly elevated risks, making precise blood pressure control essential. Despite established guidelines, current clinical practices often fail to reach optimal targets, leaving many patients vulnerable to preventable health complications. ## Spironolactone in Stroke Recovery The REDUCE trial investigated using spironolactone, a common diuretic, immediately following a stroke. Results indicated that patients receiving this medication were more likely to achieve blood pressure levels below 130/80 mm Hg after three months. A reduction of just 7 mm Hg is associated with a 38% lower risk of recurrent stroke. ## Aggressive Targets for Stroke The OPTIMAL-STROKE study in Brazil compared a systolic target of 120 mm Hg against the standard 140 mm Hg. Patients aiming for the lower 120 mm Hg goal showed significantly fewer deaths and cardiovascular events over four years. This suggests that more intensive treatment protocols could improve long-term outcomes for stroke survivors. ## Diabetes Treatment Findings Conversely, the OPTIMAL-DIABETES trial found neutral results when targeting systolic blood pressure below 120 mm Hg in type 2 diabetes patients. Compared to the 140 mm Hg threshold, the aggressive target did not reduce major cardiovascular events or deaths. This highlights the uncertainty surrounding ideal blood pressure targets for diabetic populations. ## Clinical Monitoring Requirements Achieving lower blood pressure targets requires rigorous medical supervision, particularly regarding kidney function. While the OPTIMAL-STROKE study reported no increase in end-stage renal disease or dialysis needs, some electrolyte imbalances were observed. These changes were consistent with diuretic usage, necessitating careful patient monitoring to ensure safety during intensive blood pressure management. ## Fragmentation of Patient Care A major barrier to effective treatment is the fragmented nature of post-stroke care. Neurologists, primary care physicians, and nephrologists often manage different aspects of a patient's health, complicating medication adherence. Experts note that one in five stroke survivors discontinues their antihypertensive medications within one year, highlighting a critical gap in follow-up. ## Nuanced Treatment Approaches Experts suggest moving toward more nuanced treatment strategies rather than lumping all patients into singular categories. Differences in age, gender, and specific medical history may dictate how aggressively blood pressure should be treated. Future clinical approaches must account for these variables to optimize patient care and improve long-term cardiovascular health outcomes. ## The Challenge of Implementation The primary hurdle in modern medicine is not identifying the correct targets, but determining how to implement them effectively. Clinicians emphasize that the transition from hospital-based neurological care to primary care remains a significant operational challenge. Improving coordination between specialties is essential to translate research findings into consistent, life-saving clinical practice. ## Sources covering this story - https://www.statnews.com/2026/11/07/new-studies-on-blood-pressure-management-aha-conference-news/?utm_campaign=rss — --- _Summary written by Brifing from the original reporting. Copyright in the original article belongs to its publisher; read the full piece at the link above._